Naomi M. Hamburg, MD, MS

Joseph A. Vita, MD Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Hamburg is the inaugural Joseph A. Vita Professor of Medicine, Chief of the Vascular Biology Section, interim Director of the Whitaker Cardiovascular Institute at Boston University School of Medicine and an Attending in the Cardiovascular Medicine Section at Boston Medical Center. Dr. Hamburg is a recognized expert in the field of Vascular Medicine and the clinical translation of Vascular Biology. Her research work seeks to understand approaches to restore vascular health in patients with cardiometabolic disorders, peripheral artery disease, and to evaluate the impact of novel tobacco products and long COVID. Her work has been continuously funded by the National Institutes of Health and foundations since 2006. Dr. Hamburg has held multiple leadership positions in the field of Vascular Medicine including as the Chair of the Peripheral Vascular Disease Council of the American Heart Association, and as a member of the Board of the Society of Vascular Medicine, the American Society of Echocardiography and the Vascular Testing Division of the Intersocietal Accreditation Commission. She co-Chaired the Advanced Training Statement for Vascular Medicine from the American College of Cardiology and the Society of Vascular Medicine. Dr. Hamburg has authored more than 150 scientific papers in the peer reviewed literature and has served on guideline writing committees. She is a past Associate Editor of the journal Vascular Medicine, and current Associate Editor for Circulation Research. She is passionate about improving the care of vascular diseases and reducing the burden of PAD through education. When not working, she enjoys spending time in the mountains hiking and skiing with her husband and two teenage sons.

Publications

  • Published 5/16/2025

    Zhao J, Hong H, Zhai J, Poudel R, Srivastava S, Stokes AC, Lorkiewicz PK, Jiang T, Robertson RM, Bhatnagar A, Hall JL, Hamburg NM, Keith RJ. Clustering analysis of volatile organic compound biomarkers with tobacco exposure and the association with cardiovascular health outcomes in an observation study cohort. Tob Induc Dis. 2025; 23. PMID: 40386170.

    Read at: PubMed

  • Published 5/1/2025

    Knauss HM, Ambatipudi M, Kosyakovsky LB, Herzig MS, Wang JK, Liu EE, Lau ES, McNeill JN, Shi X, Gerszten RE, Hamburg NM, Lewis GD, Robbins JM, Ho JE. Trans-right ventricle metabolite gradients in obesity highlight multiple metabolic pathways. Physiol Rep. 2025 May; 13(9):e70323. PMID: 40350961.

    Read at: PubMed

  • Published 5/1/2025

    McDermott MM, Kadian-Dodov D, Aronow HA, Beckman JA, Bolden DM, Castro-Dominguez YS, Creager MA, Criqui MH, Goodney PP, Gornik HL, Hamburg NM, Leeper NJ, Olin JW, Ross E, Bonaca MP. Research priorities for peripheral artery disease: A statement from the Society for Vascular Medicine. Vasc Med. 2025 May 01; 1358863X251330583. PMID: 40310104.

    Read at: PubMed

  • Published 2/27/2025

    Kaur G, Hamburg NM, Lau ES. Better Late Than Early? The Role of the Vascular Endothelium in Late-Onset Menopause. Circ Res. 2025 Feb 28; 136(5):470-472. PMID: 40014681.

    Read at: PubMed

  • Published 2/5/2025

    Cooper LL, Majid S, Wang N, Fetterman JL, Palmisano JN, Benjamin EJ, Vasan RS, Mitchell GF, Hamburg NM. Cross-sectional and longitudinal associations of smoking behaviour with central arterial haemodynamic measures: the Framingham Heart Study. Eur J Prev Cardiol. 2025 Feb 05. PMID: 39907713.

    Read at: PubMed

View All 235 Publications:   View Full Profile in BUMC

Other Positions

  • Section Chief, Medicine
    Boston University Chobanian & Avedisian School of Medicine
  • Investigator
    Framingham Heart Study
  • Interim Director, Whitaker Cardiovascular Institute
    Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University

Websites

Education

  • Harvard Medical School, MD
  • Harvard University, AB

View all profiles